BCL-2(b세포 림프종 2) 억제제 시장은 2023-2028년 22억 8,890만 달러로 예측되며, 예측 기간 동안 15.2%의 CAGR로 성장할 것으로 예상됩니다. BCL-2(b세포 림프종 2) 억제제 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.
현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 전 세계 노인 인구의 증가, 혈액 악성 종양에 대한 인식 증가, BCL-2 억제제의 높은 표적 친화성과 특이성으로 인해 주도되고 있습니다.
| 시장 범위 |
| 기준 연도 |
2024년 |
| 종료 연도 |
2028년 |
| 예측 기간 |
2024-2028년 |
| 성장 모멘텀 |
가속 |
| 전년 대비[2024년] |
12.86% |
| CAGR |
15.2% |
| 증분 금액 |
22억 8,890만 달러 |
이 보고서는 환자 지원 프로그램의 증가가 향후 몇 년간 BCL-2(b세포 림프종 2) 억제제 시장 성장을 견인할 주요 요인 중 하나라고 분석했습니다. 또한, 병용요법 승인 확대와 신규 제제 시장 개척 증가는 시장 수요를 크게 견인할 것으로 예상했습니다.
목차
제1장 주요 요약
제2장 시장 상황
제3장 시장 규모 평가
- 시장 정의
- 시장 부문 분석
- 시장 규모 2023년
- 시장 전망 2023-2028년
제4장 시장 규모 실적
- BCL-2(b세포 림프종 2) 억제제 세계 시장 2018-2022년
- 제품별 부문 분석 2018-2022년
- 유형별 부문 분석 2018-2022년
- 지역별 부문 분석 2018-2022년
- 국가별 부문 분석 2018-2022년
제5장 Five Forces 분석
- Five Forces 요약
- 구매자의 교섭력
- 공급 기업의 교섭력
- 신규 참여업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 상황
제6장 시장 세분화 : 제품별
- 시장 세분화
- 비교 : 제품별
- 병용요법 : 시장 규모와 예측 2023-2028년
- 단독요법 : 시장 규모와 예측 2023-2028년
- 시장 기회 : 제품별
제7장 시장 세분화 : 유형별
- 시장 세분화
- 비교 : 유형별
- 미만성 대세포형 B세포 림프종(DLBCL) : 시장 규모와 예측 2023-2028년
- 여포성 림프종 : 시장 규모와 예측 2023-2028년
- 만성 림프구성 백혈병 : 시장 규모와 예측 2023-2028년
- 외투세포림프종(MCL) : 시장 규모와 예측 2023-2028년
- 시장 기회 : 유형별
제8장 고객 상황
제9장 지역별 상황
- 지역별 세분화
- 비교 : 지역별
- 북미 : 시장 규모와 예측 2023-2028년
- 유럽 : 시장 규모와 예측 2023-2028년
- 아시아 : 시장 규모와 예측 2023-2028년
- 기타 : 시장 규모와 예측 2023-2028년
- 미국 : 시장 규모와 예측 2023-2028년
- 캐나다 : 시장 규모와 예측 2023-2028년
- 독일 : 시장 규모와 예측 2023-2028년
- 영국 : 시장 규모와 예측 2023-2028년
- 프랑스 : 시장 규모와 예측 2023-2028년
- 시장 기회 : 지역 상황별
제10장 촉진요인, 과제, 기회, 억제요인
- 시장 성장 촉진요인
- 시장 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회·억제요인
제11장 경쟁 상황
제12장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- AbbVie Inc.
- Danaher Corp.
- Amgen Inc.
- Ascentage Pharma Group International
- AstraZeneca Plc
- BeiGene Ltd.
- Bio Techne Corp.
- Biorbyt Ltd.
- Bristol Myers Squibb Co.
- F. Hoffmann La Roche Ltd.
- Merck and Co. Inc.
- Novartis AG
- Santa Cruz Biotechnology Inc.
- Seagen Inc.
- Les Laboratoires Servier
제13장 부록
ksm
The BCL-2 (B-Cell Lymphoma 2) inhibitors market is forecasted to grow by USD 2288.9 mn during 2023-2028, accelerating at a CAGR of 15.2% during the forecast period. The report on the BCL-2 (B-Cell Lymphoma 2) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising geriatric population globally, growing awareness about hematological malignancies, and high target affinity and specificity of BCL-2 inhibitors.
Technavio's BCL-2 (B-Cell Lymphoma 2) inhibitors market is segmented as below:
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 12.86% |
| CAGR | 15.2% |
| Incremental Value | $2288.9 mn |
By Product
- Combination therapy
- Monotherapy
By Type
- Diffuse large B-cell lymphoma (DLBCL)
- Follicular lymphoma
- Chronic lymphocytic leukemia
- Mantle cell lymphoma (MCL)
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increase in number of patient assistance programs as one of the prime reasons driving the BCL-2 (B-Cell Lymphoma 2) inhibitors market growth during the next few years. Also, growing approval of combination therapy and increase in development of novel formulations will lead to sizable demand in the market.
The report on the BCL-2 (B-Cell Lymphoma 2) inhibitors market covers the following areas:
- BCL-2 (B-Cell Lymphoma 2) inhibitors market sizing
- BCL-2 (B-Cell Lymphoma 2) inhibitors market forecast
- BCL-2 (B-Cell Lymphoma 2) inhibitors market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading BCL-2 (B-Cell Lymphoma 2) inhibitors market vendors that include AbbVie Inc., Danaher Corp., Amgen Inc., Ascentage Pharma Group International, AstraZeneca PLC, BeiGene Ltd., Bio Techne Corp., Biorbyt Ltd., Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Ipsen Pharma, Merck and Co. Inc., Novartis AG, Santa Cruz Biotechnology Inc., Seagen Inc., Les Laboratoires Servier, and Eli Lilly and Co.. Also, the BCL-2 (B-Cell Lymphoma 2) inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global BCL-2 (B-Cell Lymphoma 2) Inhibitors Market 2018 - 2022
- Historic Market Size - Data Table on Global BCL-2 (B-Cell Lymphoma 2) Inhibitors Market 2018 - 2022 ($ million)
- 4.2 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ million)
- 4.3 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
- 6.1 Market segments
- Chart on Product - Market share 2023-2028 (%)
- Data Table on Product - Market share 2023-2028 (%)
- 6.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 6.3 Combination therapy - Market size and forecast 2023-2028
- Chart on Combination therapy - Market size and forecast 2023-2028 ($ million)
- Data Table on Combination therapy - Market size and forecast 2023-2028 ($ million)
- Chart on Combination therapy - Year-over-year growth 2023-2028 (%)
- Data Table on Combination therapy - Year-over-year growth 2023-2028 (%)
- 6.4 Monotherapy - Market size and forecast 2023-2028
- Chart on Monotherapy - Market size and forecast 2023-2028 ($ million)
- Data Table on Monotherapy - Market size and forecast 2023-2028 ($ million)
- Chart on Monotherapy - Year-over-year growth 2023-2028 (%)
- Data Table on Monotherapy - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Type
- 7.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
- 7.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 7.3 Diffuse large B-cell lymphoma (DLBCL) - Market size and forecast 2023-2028
- Chart on Diffuse large B-cell lymphoma (DLBCL) - Market size and forecast 2023-2028 ($ million)
- Data Table on Diffuse large B-cell lymphoma (DLBCL) - Market size and forecast 2023-2028 ($ million)
- Chart on Diffuse large B-cell lymphoma (DLBCL) - Year-over-year growth 2023-2028 (%)
- Data Table on Diffuse large B-cell lymphoma (DLBCL) - Year-over-year growth 2023-2028 (%)
- 7.4 Follicular lymphoma - Market size and forecast 2023-2028
- Chart on Follicular lymphoma - Market size and forecast 2023-2028 ($ million)
- Data Table on Follicular lymphoma - Market size and forecast 2023-2028 ($ million)
- Chart on Follicular lymphoma - Year-over-year growth 2023-2028 (%)
- Data Table on Follicular lymphoma - Year-over-year growth 2023-2028 (%)
- 7.5 Chronic lymphocytic leukemia - Market size and forecast 2023-2028
- Chart on Chronic lymphocytic leukemia - Market size and forecast 2023-2028 ($ million)
- Data Table on Chronic lymphocytic leukemia - Market size and forecast 2023-2028 ($ million)
- Chart on Chronic lymphocytic leukemia - Year-over-year growth 2023-2028 (%)
- Data Table on Chronic lymphocytic leukemia - Year-over-year growth 2023-2028 (%)
- 7.6 Mantle cell lymphoma (MCL) - Market size and forecast 2023-2028
- Chart on Mantle cell lymphoma (MCL) - Market size and forecast 2023-2028 ($ million)
- Data Table on Mantle cell lymphoma (MCL) - Market size and forecast 2023-2028 ($ million)
- Chart on Mantle cell lymphoma (MCL) - Year-over-year growth 2023-2028 (%)
- Data Table on Mantle cell lymphoma (MCL) - Year-over-year growth 2023-2028 (%)
- 7.7 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.11 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
- 12.1 Companies profiled
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 12.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- 12.4 Danaher Corp.
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key news
- Danaher Corp. - Key offerings
- Danaher Corp. - Segment focus
- 12.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- 12.6 Ascentage Pharma Group International
- Ascentage Pharma Group International - Overview
- Ascentage Pharma Group International - Product / Service
- Ascentage Pharma Group International - Key offerings
- 12.7 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- 12.8 BeiGene Ltd.
- BeiGene Ltd. - Overview
- BeiGene Ltd. - Business segments
- BeiGene Ltd. - Key offerings
- BeiGene Ltd. - Segment focus
- 12.9 Bio Techne Corp.
- Bio Techne Corp. - Overview
- Bio Techne Corp. - Business segments
- Bio Techne Corp. - Key news
- Bio Techne Corp. - Key offerings
- Bio Techne Corp. - Segment focus
- 12.10 Biorbyt Ltd.
- Biorbyt Ltd. - Overview
- Biorbyt Ltd. - Product / Service
- Biorbyt Ltd. - Key offerings
- 12.11 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- 12.12 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- 12.13 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- 12.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- 12.15 Santa Cruz Biotechnology Inc.
- Santa Cruz Biotechnology Inc. - Overview
- Santa Cruz Biotechnology Inc. - Product / Service
- Santa Cruz Biotechnology Inc. - Key offerings
- 12.16 Seagen Inc.
- Seagen Inc. - Overview
- Seagen Inc. - Key offerings
- 12.17 Les Laboratoires Servier
- Les Laboratoires Servier - Overview
- Les Laboratoires Servier - Business segments
- Les Laboratoires Servier - Key offerings
- Les Laboratoires Servier - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- 13.5 Data procurement
- 13.6 Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- 13.9 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
